Note: Where available, the PDF/Word icon below is provided to view the complete and fully formatted document
 Download PDFDownload PDF 

Previous Fragment    Next Fragment


Senator Fierravanti-Wells, pursuant to notice of motion not objected to as a formal motion, moved business of the Senate notice of motion no. 3—That the following matter be referred to the Finance and Public Administration References Committee for inquiry and report by 18 August 2011:

The Government's administration of the Pharmaceutical Benefits Scheme (PBS), with particular reference to:

 (a) the deferral of listing medicines on the PBS that have been recommended by the Pharmaceutical Benefits Advisory Committee;

 (b) any consequences for patients of such deferrals;

 (c) any consequences for the pharmaceutical sector of such deferrals;

 (d) any impacts on the future availability of medicines in the Australian market due to such deferrals;

 (e) the criteria and advice used to determine medicines to be deferred;

 (f) the financial impact on the Commonwealth Budget of deferring the listing of medicines;

 (g) the consultation process prior to a deferral;

 (h) compliance with the intent of the Memorandum of Understanding signed with Medicines Australia in May 2010; and

 (i) any other related matter.

Question put and passed.